Synthesis, Biological Evaluation and In Silico Studies of Certain Oxindole–Indole Conjugates as Anticancer CDK Inhibitors

por Al-Warhi, Tarfah, El Kerdawy, Ahmed M., Aljaeed, Nada, Ismael, Omnia E., Ayyad, Rezk R., Eldehna, Wagdy M., Abdel-Aziz, Hatem A., Al-Ansary, Ghada H.
Publicado 2020

Development of 2-oindolin-3-ylidene-indole-3-carbohydrazide derivatives as novel apoptotic and anti-proliferative agents towards colorectal cancer cells

por Eldehna, Wagdy M., Abo-Ashour, Mahmoud F., Al-Warhi, Tarfah, Al-Rashood, Sara T., Alharbi, Amal, Ayyad, Rezk R., Al-Khayal, Khayal, Abdulla, Maha, Abdel-Aziz, Hatem A., Ahmad, Rehan, El-Haggar, Radwan
Publicado 2020

Development of novel benzofuran-isatin conjugates as potential antiproliferative agents with apoptosis inducing mechanism in Colon cancer

por Eldehna, Wagdy M., Salem, Rofaida, Elsayed, Zainab M., Al-Warhi, Tarfah, Knany, Hamada R., Ayyad, Rezk R., Traiki, Thamer Bin, Abdulla, Maha-Hamadien, Ahmad, Rehan, Abdel-Aziz, Hatem A., El-Haggar, Radwan
Publicado 2021

1-Benzyl-5-bromo-3-hydrazonoindolin-2-ones as Novel Anticancer Agents: Synthesis, Biological Evaluation and Molecular Modeling Insights

por Al-Warhi, Tarfah, Almahli, Hadia, Maklad, Raed M., Elsayed, Zainab M., El Hassab, Mahmoud A., Alotaibi, Ohoud J., Aljaeed, Nada, Ayyad, Rezk R., Ghabour, Hazem A., Eldehna, Wagdy M., El-Ashrey, Mohamed K.
Publicado 2023